12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Company News  |  Other News

3SBio hematology, biosimilars news

3SBio's special committee of independent directors hired Jefferies as a financial advisor to review and evaluate a non-binding proposal to go private from CEO and Chairman Jing Lou and CPEChina...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >